Anavex Life Sciences Corp (AVXL)

[nidan7500]

“Sanjay’s depth of experience and track record of strategic integration of global therapeutic operations, clinical development, commercial, and state of the art medical leadership across large organizations is impressive,” said Dr. Sandrock. “He will be an important addition to the Biogen team as we continue to execute on our mission to transform the lives of patients with complex neurological and neurodegenerative disorders.”

This from todays news suggests to me a level of organizational churn/movement/confusion/uncertainty/whatever, in BIIB. Point is, if you happen to be trying to negotiate with a company (like we think AVXL is w/BIIB) during a period of organizational churn then your plans will be in the churn along w/other things. Not a good time to try to finaize a deal.

Anyone who has been through such change periods can verify this. The organization will tend to defer any changes/new ideas until the dust settles and everybody is comfortable. Could explain why what we expected to happen has not yet manifested. Just something to keep in mind, life ain't always as it appears.